Putting it Together: Drug Screening and the Patient with Substance Use

Wednesday, April 19, 2023, 12:01 AM - Sunday, April 19, 2026, 11:59 PM


AMA PRA Category 1 Credits™ (1.00 hours), Non-Physician Attendance (1.00 hours)

This module is intended to meet the requirements for DEA licensure renewal. This activity will provide an overview of common drug screening methodologies with a focus on urine drug screens and their use in clinical practice. Finally, a series-based case study will be presented to facilitate learner application of urine drug screens to the patient with substance use disorder. 

1. Provide an overview of common drug screening modalities and their clinical application
2. Review point-of-care urine drug screens available and common drugs tested
3. Provide a basic overview of opioid and benzodiazepine drug metabolism as it relates to drug screening
4. Review Confirmatory testing and its functionality compared to point-of-care testing
5. Review case studies involving urine drug screening, clinical implications, and resultant patient care

Spectrum Health Hospitals designates this Enduring Material for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

 

Spectrum Health adheres to ACCME Criteria, Standards and Policies regarding industry support of continuing medical education. Disclosure of faculty and their commercial relationships will be made prior to the activity.

Mitigation of Relevant Financial Relationships

Spectrum Health adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.